Adjuvant or salvage radiotherapy in patients with adverse pathological features after radical prostatectomy / 中华泌尿外科杂志
Junliang ZHAO; Diwei ZHAO; Yang LIU; Liru HE; Fangjian ZHOU; Yonghong LI.
Chinese Journal of Urology
; (12): 555-558, 2022.
Artículo
en Zh
| WPRIM | ID: wpr-957428
Radical prostatectomy(RP)was commonly used in localized prostate cancer. For patients with adverse pathological features (APF) after RP, it was controversial about choosing adjuvant radiotherapy or salvage radiotherapy (SRT). Recent studies have found that early salvage radiotherapy(ESRT) had both the same cancer control and reduced overtreatment compared to adjuvant radiotherapy. Nomogram and Gene Classifier(GC) could predict the risk of recurrence after RP and contribute to choose adjuvant radiotherapy or ESRT. PSMA PET/CT was more sensitive to detect distant metastasis after biochemical recurrence, which was helpful to decide whether to implement SRT.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados